Case Summary (G.R. No. 169304)
Factual Background
Phil. Pharmawealth, Inc. is a domestic pharmaceutical manufacturer and supplier to government hospitals. The Department of Health issued A.O. No. 27, s. 1998, later amended by A.O. No. 10, s. 2000, which required separate accreditation for drug suppliers and for their specific products and provided that only products accredited by the Committee shall be procured by the DOH. Respondent submitted requests for inclusion of additional items, including Penicillin G Benzathine, on May 9, 2000 and May 29, 2000. Processing guidelines indicated a result due by September 2000. In September 2000, petitioner Lopez, as chair of the pre-qualifications, bids and awards committee, issued an Invitation for Bids for 1.2 million vials of Penicillin G Benzathine. Despite no response on its accreditation request, respondent submitted a bid. At bid opening on October 11, 2000, respondent offered P82.24 per unit, a lower bid than Cathay/YSS Laboratories’ P95.00 per unit, but the contract was awarded to YSS because respondent’s specific product remained non-accredited.
Trial Court Proceedings
Respondent filed a complaint for injunction, mandamus, and damages with a prayer for a writ of preliminary injunction and/or temporary restraining order, seeking nullification of the award to YSS, declaration that respondent was the lowest complying responsible bidder, and damages against petitioners. Petitioners answered, asserting the DOH’s express reservation to accept or reject any or all bids without incurring liability and invoked state immunity. Petitioners later filed a Manifestation and Motion to dismiss asserting state immunity and challenged respondent’s representative’s authority. Respondent opposed, arguing individual petitioners were sued in both official and personal capacities and thus state immunity did not bar the claim for damages. The trial court denied the motion to dismiss by Order dated December 8, 2003, and denied reconsideration on March 15, 2004.
Court of Appeals Proceedings
Petitioners petitioned the Court of Appeals by certiorari, maintaining that the suit was effectively against the State and thus barred by sovereign immunity. The Court of Appeals, in a Decision dated May 12, 2005, affirmed the trial court’s denial of the motion to dismiss, and by Resolution dated August 9, 2005 denied petitioners’ motion for reconsideration. Petitioners thereafter filed the present petition for review in the Supreme Court.
Issue Presented
Whether the Court of Appeals erred in affirming the trial court’s denial of petitioners’ motion to dismiss on the ground of state immunity and related defenses.
Parties’ Contentions
Petitioners argued that the complaint was a suit against the State and that the DOH and its officers were immune from suit absent consent. They relied on the DOH’s reservation to accept or reject bids and invoked sovereign immunity to bar both injunctive and damage claims. Respondent contended that individual petitioners were sued in their personal capacities for acts allegedly done in bad faith and in excess of authority; that the claims for preliminary injunction and mandamus were proper against an agency; and that sovereign immunity did not bar relief that would not impose financial liability on the State or that sought redress for unauthorized official acts.
Ruling of the Supreme Court
The Supreme Court denied the petition and affirmed the Court of Appeals’ Decision of May 12, 2005 and Resolution of August 9, 2005. The Court held that the complaint adequately alleged grave abuse of discretion by petitioners in their official capacities and that judicial review of such acts is constitutionally guaranteed under Section 1, Article VIII, 1987 Constitution. The Court also ruled that the DOH was suable as to the preliminary reliefs sought because Section 1, Rule 58 allows preliminary injunctions against an agency or person and because sovereign immunity does not apply to causes of action that do not seek to impose a charge or financial liability on the State. Finally, the Court held that respondent could sue the individual petitioners for damages in their personal capacities if the challenged acts were unauthorized or in excess of their authority, subject to proof at trial; the Court did not decide on actual liability.
Legal Basis and Reasoning
The Court reiterated that suability of a government official depends on whether the official acted within official or jurisdictional capacity and whether satisfaction of a judgment would require the State to appropriate funds, invoking Section 3, Article XVI, 1987 Constitution concerning the rule that the State may not be sued without its consent. The Court invoked precedent, including Shauf v. Court of Appeals and the decision in Director of the Bureau of Telecommunications v. Aligaen, to state that unauthorized acts of government officials are not acts of the State and therefore an action against such officials for violations of private rights is not a suit against the State with
...continue readingCase Syllabus (G.R. No. 169304)
Parties and Posture
- The Department of Health (DOH) and petitioners Secretary Manuel M. Dayrit, Usec. Ma. Margarita Galon, and Usec. Antonio M. Lopez filed a petition for review from the Court of Appeals' affirmance of the denial of their motion to dismiss.
- Phil. Pharmawealth, Inc. is the private respondent and domestic pharmaceutical manufacturer that sought accreditation and participated in a government bid for Penicillin G Benzathine.
- The petition assailed the Court of Appeals Decision dated May 12, 2005 and Resolution dated August 9, 2005 in CA-G.R. SP No. 84457.
- The relief sought in the instant petition was dismissal based principally on the doctrine of state immunity and lack of authority of respondent's representative.
Key Facts
- A.O. No. 27, s. 1998 established guidelines for accreditation of government suppliers for pharmaceutical products and was later amended by A.O. No. 10, s. 2000 to add accreditation requirements and to require product-specific accreditation.
- Phil. Pharmawealth, Inc. submitted requests for inclusion of Penicillin G Benzathine in its list of accredited products on May 9, 2000 and May 29, 2000.
- The DOH, through petitioner Usec. Antonio M. Lopez, issued an Invitation for Bids for 1.2 million vial units of Penicillin G Benzathine in September 2000.
- Phil. Pharmawealth, Inc. submitted the lowest bid at P82.24 per unit while Cathay/YSS Laboratories bid P95.00 per unit, but the award went to YSS because Pharmawealth's product lacked accreditation.
- Phil. Pharmawealth, Inc. filed a complaint for injunction, mandamus, and damages praying for nullification of the award to YSS, declaration that Pharmawealth was the lowest complying bidder, and damages against individual officials.
Procedural History
- The Regional Trial Court of Pasig City, Branch 264, denied petitioners' motion to dismiss on December 8, 2003.
- Petitioners' motion for reconsideration in the RTC was denied by Order dated March 15, 2004.
- Petitioners filed a petition for certiorari with the Court of Appeals, which affirmed the RTC Order in its Decision dated May 12, 2005 and denied reconsideration in its Resolution dated August 9, 2005.
- Petitioners elevated the case to the Supreme Court by petition for review on certiorari challenging the denial of their motion to dismiss.
Issues Presented
- Whether the Court of Appeals erred in upholding the denial of petitioners' motion to dismiss grounded on the doctrine of state immunity.
- Whether individual petitioners may be sued in their official and/or personal capacities for alleged acts relating to the award of the Penicillin G Benzathine contract.
- Whether the DOH, as an unincorporated agency, is immune from actions for preliminary injunction and mandamus.
Contentions of the Parties
- Petitioners contended that the suit was effectively against the State and barred by state immunity, that the DOH had reserved the right to accept or reject bids without liability, and that respondent's representative lacked proper board authorization.